Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model

Samuel Jay Pirruccello, Hirokazu Nakamine, Kirk W. Beisel, Kimberly L. Kleveland, Motohiko Okano, Yuichi Taguchi, Jack R. Davis, Mark L. Mahloch, David T. Purtilo

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In the course of evaluating the severe combined immunodeficiency mouse- human peripheral blood lymphocyte (SCID-PBL) model of lymphoproliferative disease, we noted hemagglutination occurring in peripheral blood smears of mice with serum human immunoglobulin levels greater than 1.0 mg/ml. The hemagglutinating process was mediated by human anti-mouse red cell antibodies of the IgM class, peaked at five to seven weeks post-transfer of 5 to 7 x 107 human PBL and was generally self limiting. However, death resulted in some mice when serum immunoglobulin levels were greater than 3.0 mg/ml. The most severely affected mice had hemagglutination induced congestion of liver, lungs and spleen. Several mice also had lesions consistent with graft-versus- host disease (GVHD) including focal hepatic necrosis and destruction of mouse splenic hematopoietic elements. The lesions associated with hemagglutination and GVHD in SCID-PBL mice are distinct from those associated with EBV-induced lymphoproliferation. Recognition of these pathologic processes are required for a thorough understanding of the SCID-PBL model.

Original languageEnglish (US)
Pages (from-to)1187-1194
Number of pages8
JournalAmerican Journal of Pathology
Volume140
Issue number5
StatePublished - Jan 1 1992

Fingerprint

Severe Combined Immunodeficiency
Hemagglutination
Graft vs Host Disease
Lymphocytes
Immunoglobulins
Immunoglobulin Isotypes
Liver
Pathologic Processes
Serum
Human Herpesvirus 4
Immunoglobulin M
Necrosis
Spleen

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Pirruccello, S. J., Nakamine, H., Beisel, K. W., Kleveland, K. L., Okano, M., Taguchi, Y., ... Purtilo, D. T. (1992). Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. American Journal of Pathology, 140(5), 1187-1194.

Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. / Pirruccello, Samuel Jay; Nakamine, Hirokazu; Beisel, Kirk W.; Kleveland, Kimberly L.; Okano, Motohiko; Taguchi, Yuichi; Davis, Jack R.; Mahloch, Mark L.; Purtilo, David T.

In: American Journal of Pathology, Vol. 140, No. 5, 01.01.1992, p. 1187-1194.

Research output: Contribution to journalArticle

Pirruccello, SJ, Nakamine, H, Beisel, KW, Kleveland, KL, Okano, M, Taguchi, Y, Davis, JR, Mahloch, ML & Purtilo, DT 1992, 'Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model', American Journal of Pathology, vol. 140, no. 5, pp. 1187-1194.
Pirruccello, Samuel Jay ; Nakamine, Hirokazu ; Beisel, Kirk W. ; Kleveland, Kimberly L. ; Okano, Motohiko ; Taguchi, Yuichi ; Davis, Jack R. ; Mahloch, Mark L. ; Purtilo, David T. / Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. In: American Journal of Pathology. 1992 ; Vol. 140, No. 5. pp. 1187-1194.
@article{9e5e463792aa4a828bf9d36b6f2a1a18,
title = "Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model",
abstract = "In the course of evaluating the severe combined immunodeficiency mouse- human peripheral blood lymphocyte (SCID-PBL) model of lymphoproliferative disease, we noted hemagglutination occurring in peripheral blood smears of mice with serum human immunoglobulin levels greater than 1.0 mg/ml. The hemagglutinating process was mediated by human anti-mouse red cell antibodies of the IgM class, peaked at five to seven weeks post-transfer of 5 to 7 x 107 human PBL and was generally self limiting. However, death resulted in some mice when serum immunoglobulin levels were greater than 3.0 mg/ml. The most severely affected mice had hemagglutination induced congestion of liver, lungs and spleen. Several mice also had lesions consistent with graft-versus- host disease (GVHD) including focal hepatic necrosis and destruction of mouse splenic hematopoietic elements. The lesions associated with hemagglutination and GVHD in SCID-PBL mice are distinct from those associated with EBV-induced lymphoproliferation. Recognition of these pathologic processes are required for a thorough understanding of the SCID-PBL model.",
author = "Pirruccello, {Samuel Jay} and Hirokazu Nakamine and Beisel, {Kirk W.} and Kleveland, {Kimberly L.} and Motohiko Okano and Yuichi Taguchi and Davis, {Jack R.} and Mahloch, {Mark L.} and Purtilo, {David T.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "140",
pages = "1187--1194",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model

AU - Pirruccello, Samuel Jay

AU - Nakamine, Hirokazu

AU - Beisel, Kirk W.

AU - Kleveland, Kimberly L.

AU - Okano, Motohiko

AU - Taguchi, Yuichi

AU - Davis, Jack R.

AU - Mahloch, Mark L.

AU - Purtilo, David T.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - In the course of evaluating the severe combined immunodeficiency mouse- human peripheral blood lymphocyte (SCID-PBL) model of lymphoproliferative disease, we noted hemagglutination occurring in peripheral blood smears of mice with serum human immunoglobulin levels greater than 1.0 mg/ml. The hemagglutinating process was mediated by human anti-mouse red cell antibodies of the IgM class, peaked at five to seven weeks post-transfer of 5 to 7 x 107 human PBL and was generally self limiting. However, death resulted in some mice when serum immunoglobulin levels were greater than 3.0 mg/ml. The most severely affected mice had hemagglutination induced congestion of liver, lungs and spleen. Several mice also had lesions consistent with graft-versus- host disease (GVHD) including focal hepatic necrosis and destruction of mouse splenic hematopoietic elements. The lesions associated with hemagglutination and GVHD in SCID-PBL mice are distinct from those associated with EBV-induced lymphoproliferation. Recognition of these pathologic processes are required for a thorough understanding of the SCID-PBL model.

AB - In the course of evaluating the severe combined immunodeficiency mouse- human peripheral blood lymphocyte (SCID-PBL) model of lymphoproliferative disease, we noted hemagglutination occurring in peripheral blood smears of mice with serum human immunoglobulin levels greater than 1.0 mg/ml. The hemagglutinating process was mediated by human anti-mouse red cell antibodies of the IgM class, peaked at five to seven weeks post-transfer of 5 to 7 x 107 human PBL and was generally self limiting. However, death resulted in some mice when serum immunoglobulin levels were greater than 3.0 mg/ml. The most severely affected mice had hemagglutination induced congestion of liver, lungs and spleen. Several mice also had lesions consistent with graft-versus- host disease (GVHD) including focal hepatic necrosis and destruction of mouse splenic hematopoietic elements. The lesions associated with hemagglutination and GVHD in SCID-PBL mice are distinct from those associated with EBV-induced lymphoproliferation. Recognition of these pathologic processes are required for a thorough understanding of the SCID-PBL model.

UR - http://www.scopus.com/inward/record.url?scp=0026720355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026720355&partnerID=8YFLogxK

M3 - Article

C2 - 1580330

AN - SCOPUS:0026720355

VL - 140

SP - 1187

EP - 1194

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -